CollPlant Biotechnologies Ltd research brief

CIK 1631487 Copy CIK

Generated Nov. 3, 2026, 12:59 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: REHOVOT L3. Reported legal jurisdiction: ISRAEL. These do not establish investor residence or where funds were deployed.

• Oct. 22, 2026 · D · 0001213900-26-111756 · Source evidence

  Reported offering amount: 9249958 USD. Reported amount sold: 9249958 USD.

• July 20, 2026 · D · 0001213900-26-079611 · Source evidence

  Reported offering amount: 10400000 USD. Reported amount sold: 10400000 USD.

• Feb. 17, 2026 · D · 0001213900-26-016910 · Source evidence

  Reported offering amount: 4000000 USD. Reported amount sold: 4000000 USD.

• June 4, 2025 · D · 0001213900-25-050961 · Source evidence

  Reported offering amount: 3870006 USD. Reported amount sold: 3870006 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “CollPlant Biotechnologies Ltd research brief,” CIK 1631487, retrieved Nov. 3, 2026, 12:59 a.m.. Cite the specific accessions used. No amounts have been summed.